昭衍新藥：預(yù)計(jì)前三季度凈利潤(rùn)同比增加約144.8%到164.8%

array(1) { [447705]=> array(2) { [2]=> array(3) { [0]=> string(9) "凈利潤(rùn)" [1]=> string(9) "三季報(bào)" [2]=> string(12) "昭衍新藥" } [4]=> array(1) { [0]=> string(19) "同花順7x24快訊" } } }